Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
374.20    0.90 (0.24%)
Bid:
374.10
Ask:
374.30
Spread: 0.20 (0.053%)
Market Cap: £7.69b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Marks and Spencer Chairmanship

14 Oct 2025 10:00

RNS Number : 2905D
Marks and Spencer Group PLC
14 October 2025
 

MARKS AND SPENCER GROUP PLC

(the 'Company')

MARKS AND SPENCER CHAIRMANSHIP

After extensive consultation with shareholders, executives, and advisers the Committee of Non-Executive Directors, led by the Senior Independent Director Fiona Dawson CBE, has decided to extend Archie Norman's tenure as Chairman for the next phase of the "reshaping of M&S" growth strategy. Archie started as Chairman in 2017 and therefore will reach the "comply or explain" nine-year point in eleven months' time. The Board is unanimous in its conviction that his continuation as Chairman is in the best interests of the Company and there is widespread support for this view across the shareholder base. M&S is a rapidly changing business with a recently strengthened executive team but there is a long way to go in delivering the Reshaping for Growth strategy and the Company will benefit from the continued strong leadership and stability Archie's Chairmanship will bring.The extension of his term will, in principle, last for three years from September 2026 but will be subject to a comprehensive annual review by a committee of independent directors and no major change of circumstances. The appointment will be put to annual shareholder approval at the AGM in the normal way. 

 

Fiona Dawson commented, "Archie has been an exceptional Chair, steering an effective, engaged Board and putting in place a highly capable leadership team under Stuart Machin which is transforming M&S and building a stronger, better business. There remains much to do, and Archie's deep knowledge of the business, drive and unique experience will be invaluable as we move to the next phase of the Reshaping for Growth plan."

 

-Ends-

 

For more information, please call:

Corporate Press Office: +44 (0) 20 8718 1919

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUSSWRVSURARA
Date   Source Headline
28th Nov 20232:55 pmRNSDirector/PDMR Shareholding
9th Nov 202310:29 amRNSDirector/PDMR Shareholding
8th Nov 20237:00 amRNSHalf-year Report
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:01 pmRNSDirector/PDMR Shareholding
2nd Oct 20239:00 amRNSTotal Voting Rights
28th Sep 20233:18 pmRNSDirector/PDMR Shareholding
20th Sep 20233:33 pmRNSHolding(s) in Company
20th Sep 20239:00 amRNSDirector/PDMR Shareholding
19th Sep 20239:01 amRNSDirector/PDMR Shareholding
1st Sep 20239:00 amRNSTotal Voting Rights
30th Aug 202310:34 amRNSDirector/PDMR Shareholding
16th Aug 20233:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSTrading Update and Outlook for the Year
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 202311:33 amRNSDirector/PDMR Shareholding
7th Jul 20234:18 pmRNSDirector/PDMR Shareholding
4th Jul 20232:13 pmRNSResult of AGM
3rd Jul 20239:00 amRNSTotal Voting Rights
3rd Jul 20239:00 amRNSBlock listing Interim Review
28th Jun 20232:01 pmRNSDirector/PDMR Shareholding
19th Jun 20234:41 pmRNSDirector/PDMR Shareholding
8th Jun 20235:01 pmRNSHolding(s) in Company
7th Jun 20232:56 pmRNSHolding(s) in Company
6th Jun 202310:00 amRNSAnnual Financial Report
1st Jun 202312:19 pmRNSDirector/PDMR Shareholding
1st Jun 20239:00 amRNSTotal Voting Rights
24th May 20237:00 amRNSFinal Results
2nd May 20239:00 amRNSTotal Voting Rights
28th Apr 202310:40 amRNSDirector/PDMR Shareholding
3rd Apr 20239:00 amRNSTotal Voting Rights
28th Mar 20232:04 pmRNSDirector/PDMR Shareholding
20th Mar 20233:53 pmRNSHolding(s) in Company
1st Mar 20239:00 amRNSTotal Voting Rights
28th Feb 202310:23 amRNSDirector/PDMR Shareholding
24th Feb 20239:00 amRNSDirectorate Change
1st Feb 20239:00 amRNSTotal Voting Rights
30th Jan 202310:18 amRNSDirector/PDMR Shareholding
16th Jan 20231:35 pmRNSHolding(s) in Company
16th Jan 202310:30 amRNSChange to Board Committee Membership
13th Jan 20234:16 pmRNSHolding(s) in Company
12th Jan 20237:00 amRNSChristmas 2022/2023 Trading
5th Jan 20234:02 pmRNSHolding(s) in Company
3rd Jan 20239:00 amRNSTotal Voting Rights
3rd Jan 20239:00 amRNSBlock listing Interim Review
29th Dec 202210:40 amRNSDirector/PDMR Shareholding
13th Dec 202210:37 amRNSDirector Declaration
12th Dec 20221:45 pmRNSDirectorate Change
9th Dec 20223:27 pmRNSDirector/PDMR Shareholding
1st Dec 20229:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.